sr 95531 has been researched along with tiletamine hydrochloride in 1 studies
Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (tiletamine hydrochloride) | Trials (tiletamine hydrochloride) | Recent Studies (post-2010) (tiletamine hydrochloride) |
---|---|---|---|---|---|
610 | 0 | 209 | 2,819 | 12 | 1,228 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bisogno, T; Brussaard, AB; Burnashev, N; Canto, CB; Di Marzo, V; Heistek, TS; Lodder, JC; Mansvelder, HD; Min, R; Testa-Silva, G | 1 |
1 other study(ies) available for sr 95531 and tiletamine hydrochloride
Article | Year |
---|---|
Diacylglycerol lipase is not involved in depolarization-induced suppression of inhibition at unitary inhibitory connections in mouse hippocampus.
Topics: Animals; Animals, Newborn; Benzoxazines; Cyclohexanones; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; GABA Antagonists; Green Fluorescent Proteins; Hippocampus; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Lipoprotein Lipase; Lysine; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Neocortex; Neural Inhibition; Neurons; Pyridazines; Quinoxalines; Receptor, Cannabinoid, CB1; Valine | 2010 |